<?xml version="1.0" encoding="UTF-8"?>
<p id="par0155">Another risk (hypothesised in an animal model) is related to a possible decrease in the immune response of the patient against the virus due to the passive immunisation following antibody administration with plasma, leaving patients more susceptible to reinfection. This event must be clearly taken into account and evaluated [
 <xref rid="bib0100" ref-type="bibr">20</xref>].
</p>
